Several genetic mutations of microglia-specific genes have been identified as risks for AD, including TREM2 (Triggering receptor expressed on myeloid cells 2) [20, 21], CD33 [22] and MS4A [5, 8]. Here, TREM2 is linked to Alzheimer disease.